Pulmonary surfactant is a critical component of lung function in healthy individuals. It
functions in part by lowering surface tension in the alveoli, thereby allowing for breathing …

Pulmonary drug delivery is a highly attractive topic for the treatment of infectious lung
diseases. Drug delivery via the pulmonary route offers unique advantages of no first-pass …

INTRODUCTION Current influenza vaccines must be refreshed annually to address constant
mutations of viral hemagglutinin (HA) and neuraminidase (NA) genes because the vaccines …

Respiratory distress syndrome (RDS) due to surfactant deficiency is the most common cause
of respiratory failure in preterm infants. Tremendous progress has been made since the …

Pulmonary surfactant (PS) constitutes the first line of host defense in the deep lung. Because
of its high content of phospholipids and surfactant specific proteins, the interaction of inhaled …

The COVID-19 pandemic caused by SARS-CoV-2 seriously threatens global public health. It
has previously been confirmed that SARS-CoV-2 is mainly transmitted between people …

The rapid development of nanotechnology is opening a huge world of promising
possibilities in healthcare, but this is also increasing the necessity to study the potential risk …

Pulmonary surfactant (PS) is a lipid-protein complex essential to stabilise the delicate
structure of mammalian alveoli along with successive compression-expansion respiratory …

Pulmonary surfactant is a lipid/protein complex synthesized by the alveolar epithelium and
secreted into the airspaces, where it coats and protects the large respiratory air–liquid …

Pulmonary surfactant (PS) has been extensively studied because of its primary role in
mammalian breathing. The deposition of this surface-active material at the alveolar air-water …